Home Cart 0 Sign in  

[ CAS No. 1195768-06-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1195768-06-9
Chemical Structure| 1195768-06-9
Structure of 1195768-06-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1195768-06-9 ]

Related Doc. of [ 1195768-06-9 ]

Alternatived Products of [ 1195768-06-9 ]

Product Details of [ 1195768-06-9 ]

CAS No. :1195768-06-9 MDL No. :
Formula : C24H24F3N5O5S3 Boiling Point : -
Linear Structure Formula :- InChI Key :YKGMKSIHIVVYKY-UHFFFAOYSA-N
M.W : 615.67 Pubchem ID :44516822
Synonyms :
GSK2118436 Mesylate;GSK 2118436B;Dabrafenib (mesylate)
Chemical Name :N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate

Calculated chemistry of [ 1195768-06-9 ]

Physicochemical Properties

Num. heavy atoms : 40
Num. arom. heavy atoms : 23
Fraction Csp3 : 0.21
Num. rotatable bonds : 6
Num. H-bond acceptors : 11.0
Num. H-bond donors : 3.0
Molar Refractivity : 146.69
TPSA : 210.23 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.29 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.7
Log Po/w (XLOGP3) : 3.89
Log Po/w (WLOGP) : 8.11
Log Po/w (MLOGP) : 2.3
Log Po/w (SILICOS-IT) : 5.51
Consensus Log Po/w : 4.5

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 2.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -6.14
Solubility : 0.000449 mg/ml ; 0.000000729 mol/l
Class : Poorly soluble
Log S (Ali) : -8.0
Solubility : 0.00000612 mg/ml ; 0.0000000099 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -9.57
Solubility : 0.000000167 mg/ml ; 0.0000000003 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.42

Safety of [ 1195768-06-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1195768-06-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1195768-06-9 ]
  • Downstream synthetic route of [ 1195768-06-9 ]

[ 1195768-06-9 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 75-75-2 ]
  • [ 1195765-45-7 ]
  • [ 1195768-06-9 ]
YieldReaction ConditionsOperation in experiment
87% at 20℃; for 3 h; Add methylsulfonic acid (0.131 ml, 0.393 mmol) into the isopropanol solution of N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide (204 mg, 0.393 mmol) and stir the solution at room temperature for 3 h to obtain a white precipitate, filter the slurry and wash it with ethyl ether to obtain N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazo-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide methanesulfonate, which is a white crystals (221 mg, 87percent yield).
1HNMR (400 MHz, DMSO-d6) δ ppm 10.85 (s, 1H) 7.92-8.05 (m, 1H), 7.56-7.72 (m, 1H), 6.91-7.50 (m, 7H), 5.83-5.98 (m, 1H), 2.18-2.32 (m, 3H), 1.36 (s, 9H). j0114] The X-ray powder diffraction pattern of the obtained crystals as shown in FIG. 10 is consistent with that mentioned in the patent documents W02009/137391 or CN200980126781 .6.10115] The DSC thermogram is shown in FIG. 11: the melting range of the Known Crystal Form I is 247° C.250°C.10116] The TGA thermogram is shown in FIG. 12: the decomposition temperature is 261° C.
85.1% at 20 - 60℃; Method 5: Compound B (alternative mesylate salt embodiment) - A/-{3-[5-(2-amino-4- pyrimidinyl)-2-(1 ,1 -dimethylethyl)-1 ,3-thiazol-4-yl]-2-fluorophenyl}-2,6- difluorobenzenesulfonamide methanesulfonateA/-{3-[5-(2-amino-4-pyrimidinyl)-2-(1 ,1 -dimethylethyl)-1 ,3-thiazol-4-yl]-2-fluorophenyl}- 2,6-difluorobenzenesulfonamide (as may be prepared according to example 58a) (2.37g, 4.56 mmol) was combined with pre-filtered acetonitrile (5.25 vol, 12.4 ml_). A pre-filtered solution of mesic acid (1 .1 eq., 5.02 mmol, 0.48 g) in H2O (0.75 eq., 1 .78 ml_) was added at 20°C. The temperature of the resulting mixture was raised to 50- 60°C while maintaining a low agitation speed. Once the mixture temperature reached to 50-60°C, a seed slurry of A/-{3-[5-(2-amino-4-pyrimidinyl)-2-(1 ,1 -dimethylethyl)-1 ,3- thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide methanesulfonate (1 .0 percentw/w slurried in 0.2 vol of pre-filtered acetonitrile) was added, and the mixture was aged while agitating at a speed fast enough to keep solids from settling at 50-60°C for 2 hr. The mixture was then cooled to 0-5°C at 0.25°C/min and held at 0-5°C for at 6 hr. The mixture was filtered and the wet cake was washed twice with pre-filteredacetonitrile. The first wash consisted of 14.2 ml (6 vol) pre-filtered acetonitrile and the second wash consisted of 9.5 ml (4 vol) pre-filtered acetonitrile. The wet solid was dried at 50°C under vacuum, yielding 2.39 g (85.1 percent yield) of product.
85.1% at 20 - 60℃; N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1 , 1-dimethylethyl)-1 ,3-thiazol-4-yl]-2- fluorophenyl}-2,6-difluorobenzenesulfonamide (as may be prepared according to example 58a) (2.37g, 4.56 mmol) was combined with pre-filtered acetonitrile (5.25 vol, 12.4 mL). A pre-filtered solution of mesic acid (1.1 eq., 5.02 mmol, 0.48 g) in H20 (0.75 eq., 1.78 mL) was added at 20°C. The temperature of the resulting mixture was raised to 50-60°C while maintaining a low agitation speed. Once the mixture temperature reached to 50- 60°C, a seed slurry of A/-{3-[5-(2-amino-4-pyrimidinyl)-2-(1 ,1-dimethylethyl)-1 ,3-thiazol-4- yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide methanesulfonate (1.0 percentw/w slurried in 0.2 vol of pre-filtered acetonitrile) was added, and the mixture was aged while agitating at a speed fast enough to keep solids from settling at 50-60°C for 2 hr. The mixture was then cooled to 0-5°C at 0.25°C/min and held at 0-5°C for at 6 hr. The mixture was filtered and the wet cake was washed twice with pre-filtered acetonitrile. The first wash consisted of 14.2 ml (6 vol) pre-filtered acetonitrile and the second wash consisted of 9.5 ml (4 vol) pre-filtered acetonitrile. The wet solid was dried at 50°C under vacuum, yielding 2.39 g (85.1 percent yield) of product.
85.1% at 50 - 60℃; for 2 h; Method 5: Compound B (alternative mesylate salt embodiment) - N-{3-[5-(2- amino-4-pyrimidinyl)-2-(l, 1 -dimethyl ethyl)-l,3-thiazol-4-yl]-2-fluorophenyl}-2,6- difluorobenzenesulfonamide methanesulfonate N-{3-[5-(2-amino-4-pyrimidinyl)-2-(l, l-dimethylethyl)-l,3-thiazol-4-yl]-2- fluorophenyl}-2,6-difluorobenzenesulfonamide (as may be prepared according to example 58a) (2.37g, 4.56 mmol) was combined with pre-filtered acetonitrile (5.25 vol, 12.4 mL). A pre-filtered solution of mesic acid (1.1 eq., 5.02 mmol, 0.48 g) in H20 (0.75 eq., 1.78 mL) was added at 20°C. The temperature of the resulting mixture was raised to 50-60°C while maintaining a low agitation speed. Once the mixture temperature reached to 50- 60°C, a seed slurry of N-{3-[5-(2-amino-4-pyrimidinyl)-2-(l,l-dimethylethyl)-l,3-thiazol- 4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide methanesulfonate (1.0 percentw/w slurried in 0.2 vol of pre-filtered acetonitrile) was added, and the mixture was aged while agitating at a speed fast enough to keep solids from settling at 50-60°C for 2 hr. The mixture was then cooled to 0-5°C at 0.25°C/min and held at 0-5°C for at 6 hr. The mixture was filtered and the wet cake was washed twice with pre-filtered acetonitrile. The first wash consisted of 14.2 ml (6 vol) pre-filtered acetonitrile and the second wash consisted of 9.5 ml (4 vol) pre-filtered acetonitrile. The wet solid was dried at 50°C under vacuum, yielding 2.39 g (85.1percent yield) of product.
85.1% at 20 - 60℃; for 2 h; Method 5: Dabrafenib (alternative mesylate salt embodiment) - N-{3-[5-(2-amino-4- pyrimidinyl)-2-(l,l-dimethylethyl)-l,3-thiazol-4-yl]-2-fluorophenyl}-2,6- difluorobenzenesulfonamide methanesulfonate: N-{3-[5-(2-amino-4-pyrimidinyl)-2-(l,l-dimethylethyl)-l,3-thiazol-4-yl]-2- fluorophenyl}-2,6-difluorobenzenesulfonamide (as may be prepared according to example 58a) (2.37g, 4.56 mmol) was combined with pre-filtered acetonitrile (5.25 vol, 12.4 mL). A pre- filtered solution of mesic acid (1.1 eq., 5.02 mmol, 0.48 g) in H20 (0.75 eq., 1.78 mL) was added at 20 °C. The temperature of the resulting mixture was raised to 50-60 °C while maintaining a low agitation speed. Once the mixture temperature reached to 50-60 °C, a seed slurry of N-{3- [5-(2-amino-4-pyrimidinyl)-2-(l,l-dimethylethyl)-l,3-thiazol-4-yl]-2-fluorophenyl}-2,6- difluorobenzenesulfonamide methanesulfonate (1.0 percentw/w slurried in 0.2 vol of pre-filtered acetonitrile) was added, and the mixture was aged while agitating at a speed fast enough to keep solids from settling at 50-60 °C for 2 hr. The mixture was then cooled to 0-5°C at 0.25°C/min and held at 0-5 °C for at 6 hr. The mixture was filtered and the wet cake was washed twice with pre-filtered acetonitrile. The first wash consisted of 14.2 ml (6 vol) pre-filtered acetonitrile and the second wash consisted of 9.5 ml (4 vol) pre-filtered acetonitrile. The wet solid was dried at 50 °C under vacuum, yielding 2.39 g (85.1percent yield) of product.

Reference: [1] Patent: US2016/46615, 2016, A1, . Location in patent: Paragraph 0113; 0114; 0115; 0116
[2] Patent: WO2011/47238, 2011, A1, . Location in patent: Page/Page column 20-21
[3] Patent: WO2014/195852, 2014, A1, . Location in patent: Page/Page column 31; 32
[4] Patent: WO2015/87279, 2015, A1, . Location in patent: Page/Page column 25; 26
[5] Patent: WO2017/37587, 2017, A1, . Location in patent: Page/Page column 35
  • 2
  • [ 60230-36-6 ]
  • [ 1195768-06-9 ]
Reference: [1] Patent: WO2011/47238, 2011, A1,
[2] Patent: WO2014/195852, 2014, A1,
[3] Patent: WO2015/87279, 2015, A1,
[4] Patent: WO2017/37587, 2017, A1,
  • 3
  • [ 1195768-20-7 ]
  • [ 1195768-06-9 ]
Reference: [1] Patent: WO2011/47238, 2011, A1,
[2] Patent: WO2014/195852, 2014, A1,
[3] Patent: WO2015/87279, 2015, A1,
[4] Patent: WO2017/37587, 2017, A1,
  • 4
  • [ 1195768-18-3 ]
  • [ 1195768-06-9 ]
Reference: [1] Patent: WO2011/47238, 2011, A1,
[2] Patent: WO2014/195852, 2014, A1,
[3] Patent: WO2015/87279, 2015, A1,
[4] Patent: WO2017/37587, 2017, A1,
  • 5
  • [ 1195768-19-4 ]
  • [ 1195768-06-9 ]
Reference: [1] Patent: WO2011/47238, 2011, A1,
[2] Patent: WO2014/195852, 2014, A1,
[3] Patent: WO2015/87279, 2015, A1,
[4] Patent: WO2017/37587, 2017, A1,
  • 6
  • [ 1195768-23-0 ]
  • [ 1195768-06-9 ]
Reference: [1] Patent: WO2011/47238, 2011, A1,
Same Skeleton Products
Historical Records

Similar Product of
[ 1195768-06-9 ]

Chemical Structure| 1195765-45-7

A484347[ 1195765-45-7 ]

N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

Reason: Free-salt